Sunday, 1 December 2019

Suven Life Sciences tumbles 20% as SUVN-502 misses target in phase-2 trial

As part of the study, Suven tested the drug as a unique triple combination with Aricept (donepezil) and Namenda (memantine) on 564 patients in the US for at least one year

from Markets https://ift.tt/2LeFJFv

No comments:

Post a Comment

Goldprice dips Rs 10 to Rs 62,720, silver falls Rs 100 to Rs 74,900

The price of 22-carat gold also fell Rs 10 with the yellow metal selling at Rs 57,490 from Markets https://ift.tt/rpZGNwM